Gottlieb Michael, Spatz Erica S, Yu Huihui, Wisk Lauren E, Elmore Joann G, Gentile Nicole L, Hill Mandy, Huebinger Ryan M, Idris Ahamed H, Kean Efrat R, Koo Katherine, Li Shu-Xia, McDonald Samuel, Montoy Juan Carlos C, Nichol Graham, O'Laughlin Kelli N, Plumb Ian D, Rising Kristin L, Santangelo Michelle, Saydah Sharon, Wang Ralph C, Venkatesh Arjun, Stephens Kari A, Weinstein Robert A
Department of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Open Forum Infect Dis. 2023 May 31;10(7):ofad277. doi: 10.1093/ofid/ofad277. eCollection 2023 Jul.
The prevalence, incidence, and interrelationships of persistent symptoms after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vary. There are limited data on specific phenotypes of persistent symptoms. Using latent class analysis (LCA) modeling, we sought to identify whether specific phenotypes of COVID-19 were present 3 months and 6 months post-infection.
This was a multicenter study of symptomatic adults tested for SARS-CoV-2 with prospectively collected data on general symptoms and fatigue-related symptoms up to 6 months postdiagnosis. Using LCA, we identified symptomatically homogenous groups among COVID-positive and COVID-negative participants at each time period for both general and fatigue-related symptoms.
Among 5963 baseline participants (4504 COVID-positive and 1459 COVID-negative), 4056 had 3-month and 2856 had 6-month data at the time of analysis. We identified 4 distinct phenotypes of post-COVID conditions (PCCs) at 3 and 6 months for both general and fatigue-related symptoms; minimal-symptom groups represented 70% of participants at 3 and 6 months. When compared with the COVID-negative cohort, COVID-positive participants had higher occurrence of loss of taste/smell and cognition problems. There was substantial class-switching over time; those in 1 symptom class at 3 months were equally likely to remain or enter a new phenotype at 6 months.
We identified distinct classes of PCC phenotypes for general and fatigue-related symptoms. Most participants had minimal or no symptoms at 3 and 6 months of follow-up. Significant proportions of participants changed symptom groups over time, suggesting that symptoms present during the acute illness may differ from prolonged symptoms and that PCCs may have a more dynamic nature than previously recognized. NCT04610515.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后持续症状的患病率、发病率及相互关系各不相同。关于持续症状的特定表型的数据有限。我们使用潜在类别分析(LCA)模型,试图确定感染后3个月和6个月是否存在新冠病毒病(COVID-19)的特定表型。
这是一项针对有症状成年人的多中心研究,这些成年人接受了SARS-CoV-2检测,并前瞻性收集了诊断后长达6个月的一般症状和疲劳相关症状的数据。我们使用LCA,在每个时间段的新冠病毒检测呈阳性和阴性的参与者中,针对一般症状和疲劳相关症状确定症状同质组。
在5963名基线参与者(4504名新冠病毒检测呈阳性和1459名新冠病毒检测呈阴性)中,分析时4056人有3个月的数据,2856人有6个月的数据。我们在3个月和6个月时针对一般症状和疲劳相关症状确定了4种不同的新冠后状况(PCC)表型;在3个月和6个月时,症状轻微组占参与者的70%。与新冠病毒检测呈阴性的队列相比,新冠病毒检测呈阳性的参与者味觉/嗅觉丧失和认知问题的发生率更高。随着时间的推移,存在大量的类别转换;3个月时处于1个症状类别的人在6个月时同样有可能保持不变或进入新的表型。
我们确定了一般症状和疲劳相关症状的不同类别的PCC表型。在随访的3个月和6个月时,大多数参与者症状轻微或无症状。相当比例的参与者随时间改变了症状组,这表明急性疾病期间出现的症状可能与长期症状不同,并且PCC可能比之前认为的具有更动态的性质。 临床试验注册号:NCT04610515。